# Replimune Group, Inc.: Form 8-K, filed Apr 12, 2021

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2021-04-12
- Accepted by EDGAR: Apr 12, 2021, 16:46 ET
- Period: 2021-04-10
- Accession: 0001104659-21-049367
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465921049367/tm2112766d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465921049367/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465921049367/tm2112766d1_8k.htm

Filed Apr 12, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-049367. Last ingested by Listed: Nov 6, 2026, 16:43 ET. No prices; not investment advice.